PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Lorecivivint, page-14

  1. 318 Posts.
    lightbulb Created with Sketch. 37
    Let's not lose sight that there isn't a lot out there and this may be first to market as a real alternative. We are 2 years away from our readout of phase 3
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.